Research Article

Elevated Cardiac Troponin in Acute Stroke without Acute Coronary Syndrome Predicts Long-Term Adverse Cardiovascular Outcomes

Table 1

Descriptive statistics and demographic distribution.

VariableNormal cTnI ( = 183)Elevated cTnI ( = 17) value

Age63.1 ± 10.862.7 ± 140.079
Male (%)57.9 41.20.208
African Americans (%)65.547.10.270
Smoker (%)38.341.20.800
Hypertension (%)79.264.70.217
Diabetes (%)38.347.10.606
CAD history (%)18.047.10.009
CKD (%)5.517.60.086
Systolic BP (mmHg)161.8 ± 23.2153 ± 32.80.072
Hemoglobin (g/dL)13.4 ± 2.612.2 ± 1.80.014
Creatinine (mg/dL)1.24 ± 1.01.65 ± 1.60.143
Ldl (mg/dL)119.9 ± 41109.6 ± 340.249
Peak cTnI (ng/mL)0.048 ± 0.062.04 ± 1.10.000
CK-MB (ng/mL)3.23 ± 3.119.09 ± 13.80.000
LVEF (%)50.2 ± 15.947.9 ± 21.60.008
Length of stay (days)8.7 ± 13.215.3 ± 11.20.384

CAD: coronary artery disease. CKD: chronic kidney disease. LVEF: left ventricular ejection fraction. cTnI: cardiac troponin I.